Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹132 Cr
Revenue (TTM)
₹10 Cr
Net Profit (TTM)
₹0 Cr
ROE
3.4 %
ROCE
2.5 %
P/E Ratio
525.3
P/B Ratio
12.9
Industry P/E
34.1
EV/EBITDA
391.8
Div. Yield
0 %
Debt to Equity
0
Book Value
₹7
EPS
₹0.2
Face value
10
Shares outstanding
14,649,000
CFO
₹-6.09 Cr
EBITDA
₹-0.58 Cr
Net Profit
₹2.31 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Gujarat Inject
| 151.8 | 35.8 | 126.9 | 246.2 | 127.9 | -- | -- |
|
BSE Healthcare
| -3.1 | -3.4 | -6.0 | 7.2 | 23.7 | 13.7 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Gujarat Inject
| 34.2 | 86.4 | 7.1 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Gujarat Inject
|
90.0 | 131.9 | 9.9 | 0.3 | 1.3 | 2.5 | 525.3 | 12.9 |
| 361.6 | 3,297.1 | 2,521.8 | 202.5 | 9.6 | 14.3 | 16.3 | 2.2 | |
| 1,044.3 | 12,804.5 | 2,512.3 | 543.7 | 28.3 | 19.3 | 23.6 | 4.0 | |
| 374.5 | 6,495.4 | 1,053.1 | 293.6 | 32.3 | 24.6 | 22.1 | 5.0 | |
| 1,049.8 | 10,983.7 | 1,158.7 | 309.6 | 31.9 | 17.3 | 35.1 | 5.8 | |
| 1,565.4 | 29,661.3 | 8,850.1 | 894.8 | 15.2 | 19.8 | 34.1 | 6.0 | |
| 14,055.0 | 18,026.8 | 1,575.1 | 179.1 | 14.9 | 11.4 | 100.6 | 10.9 | |
| 1,872.6 | 3,114.7 | 673.7 | 202.6 | 17.6 | 19.4 | 15.4 | 5.4 | |
| 783.3 | 3,608.1 | 588.5 | 102.9 | 22.1 | 12.7 | 35.5 | 4.3 | |
| 169.1 | 4,458.2 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 6.7 |
No Review & Analysis are available.
Manufacture of allopathic pharmaceutical preparations
Incorporated
1991
Chairman
--
Managing Director
--
Headquarters
Vadodara, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Gujarat Inject (Kerala) Ltd is ₹90.00 (BSE) as of 08-Apr-2026 IST. Gujarat Inject (Kerala) Ltd has given a return of 127.94% in the last 3 years.
The P/E ratio of Gujarat Inject (Kerala) Ltd is 525.32 times as on 08-Apr-2026, a 1441 premium to its peers’ median range of 34.10 times.
The P/B ratio of Gujarat Inject (Kerala) Ltd is 12.92 times as on 08-Apr-2026, a 490 premium to its peers’ median range of 2.19 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
135.74
|
1.99
|
|
2023
|
93.33
|
-4.57
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
|
2020
|
0.00
|
0.00
|
The 52-week high and low of Gujarat Inject (Kerala) Ltd are Rs 91.90 and Rs 17.02 as of 09-Apr-2026.
Gujarat Inject (Kerala) Ltd has a market capitalisation of ₹ 132 Cr as on 08-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Gujarat Inject (Kerala) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹1.97
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.